• Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
  • Toolkit for journalists and consumers
  • Contact
  • Newsletter Signup
NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
HealthNewsReview.org HealthNewsReview.org HealthNewsReview.org
  • 2616 Story Reviews
  • 606 News Release Reviews
  • 2936 Blog Posts
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
    • Editorial Team
    • What We Review and How
    • Review Criteria
    • How Is the Star Score Determined?
    • Our Comments Policy
    • Accolades for HealthNewsReview.org
    • Talks, Workshops & Presentations
  • Toolkit
    • Tips for Analyzing Studies & Health Care Claims
    • Just for Journalists: Writing Tips
    • Stories of Patient Harm from Misleading Media
    • Pre-publication News Release Review
    • Health News Watchdog podcasts
    • News Sites & Blogs We Like
    • List of Industry-Independent Experts
    • Links to Other Resources
  • Contact

Search Results for "Sprint"

1
blood pressure dementia
7/26/2018

Intensive blood pressure control and ‘dementia’: another mad rush to report incomplete SPRINT findings

After 12 years in which we’ve published more than 2,500 news story reviews, we’ve found that reports out of medical meetings are among the most superficial and imbalanced journalism that we evaluate. Study abstracts presented at these meetings are often pitched as urgent or a ‘breakthrough’, when actually they’re usually preliminary and yet to be […]

8
11/25/2015

Informed patients need one thing not provided in SPRINT trial news: what were the absolute benefit/harm numbers?

On November 9th, the New England Journal of Medicine published SPRINT (Systolic Blood Pressure Intervention Trial) comparing “intensive” blood pressure lowering (targeting <120 mm HG systolic) against standard therapy, (<140 mm HG) and came to pretty definitive conclusions: “SPRINT now provides evidence of benefits for an even lower systolic blood-pressure target than that currently recommended […]

2
11/9/2015

Do published SPRINT study results live up to premature NIH news release hype?

After the NIH announced preliminary findings from the much anticipated SPRINT (Systolic Blood Pressure Intervention Trial) study on managing hypertension in September it received some criticism from the medical community and health journalists for its failure to provide key details about the research. Missing were the evidence, data and the names of the drugs that were […]

2
9/18/2015

NIH SPRINT study sparks questions about overtreatment of mild hypertension

Last week the National Institutes of Health (NIH) took the unusual step of announcing the early conclusion of a “landmark” study on managing hypertension. What makes it unusual is that when the NIH made the bold announcement that intensive intervention with a combo of three drugs to reach a new target systolic blood pressure of […]

7
9/11/2015

NIH, news media, need to slow down on the SPRINT hype

This post has been updated with additional expert commentary on the SPRINT trial and the NIH’s announcement regarding the results (scroll to the bottom). The National Institutes of Health (NIH) today made an announcement about the SPRINT (Systolic Blood Pressure Intervention Trial) study that is making big waves across the world of health care. Landmark […]

4
Too Much Medicine
8/16/2018

Too Much Medicine: A small medical conference with a big impact

The Too Much Medicine (TMM) conference is small, but has a potentially huge impact.  We cover plenty of medical conferences about heart disease, cancer, and dementia (to name a few) that trigger tsunamis of media coverage because they –quite obviously and understandably — affect millions of people and involve grave outcomes. But the TMM conference, wrapping […]

3
1/26/2018

New blood pressure guidelines are promoted with scars and scare tactics

The American Heart Association (AHA) has faced criticism for issuing new, more aggressive guidelines that lower the threshold for high blood pressure and set lower treatment targets for millions of Americans. (We’ve written extensively about those guidelines and the SPRINT study that formed the basis for them.) Now the AHA is facing renewed criticism for […]

1
12/20/2017

New blood pressure guidelines: supporters get coverage, critics don’t. Why?

Last month the American College of Cardiology (ACC) and the American Heart Association (AHA) released new guidelines advising that high blood pressure (‘hypertension’) be defined at 130/80 millimeters of mercury, instead of the previously widely accepted (and higher) threshold of 140/90. The response from news organizations was massive. Last week, when the American Academy of Family […]

3
9/26/2017

A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening

With September’s Prostate Cancer Awareness Month in full swing, an industry-affiliated partnership has turned to high-profile former NFL coaches to deliver its prostate cancer screening message. It’s a clever choice: professional coaches are good at getting men to do all kinds of things they might not otherwise want to do, whether it’s extra wind sprints […]

misleading PR
2/9/2017

Tainted at the source: Misleading PR claims that flow downstream to health news consumers

  Why do we review news releases? Because the exaggerated claims sometimes made in these public relations documents can get passed along–with little independent analysis or scrutiny–to unsuspecting news consumers who may think they’re reading carefully vetted journalism. Here are two fresh examples that demonstrate how this happens and why it’s a problem. In both […]

January 23, 2017 | News Release Review

Informative release on managing ‘prehypertension’ should’ve toned down the headline

Aside from an overreaching headline and sub-headline, the news release delivers essential information including costs, harms, availability, and study limitations.

4 Star
Johns Hopkins Medicine

Personalized treatment for those in blood pressure 'gray zone'

9/22/2016

Just for journalists: Tips and case studies for writing about health care

Writing about health care is complex and nuanced. On this page for journalists, we offer 1) primers for writing about complex medical topics, 2) advice for common pitfalls healthcare journalists face, and 3) in-depth case studies on how we cracked open several important medical stories in recent years. Another page–tips for analyzing studies & health care claims–also has primers […]

7
8/30/2016

Reason number 1,001 to slow down when reporting on breaking health news

Kevin Lomangino is the managing editor of HealthNewsReview.org. He tweets as @Klomangino. We often plead for journalists and public relations people to slow down when reporting on breaking new research that makes big claims about health benefits. Whether that news is coming from a company announcement or a scientific meeting, chances are good that the […]

May 26, 2016 | News Release Review

Once again, NIH release on blood pressure targets lacks info on absolute benefits, potential harms

This quick summary of results from a large study missed an opportunity to help clarify the best way to manage high blood pressure in the elderly.

2 Star
NIH/National Heart, Lung and Blood Institute

NIH study confirms benefits of intensive blood pressure management among seniors aged 75 and older

8
12/5/2015

The Cochrane Collaboration might be “Medicine’s Best Kept Secret” (but it shouldn’t be for journalists)

Just last month, after nearly three years of investigation, I published a book on a 22-year-old organization called the Cochrane Collaboration. The book’s subtitle, “Medicine’s Best Kept Secret,” was meant to be a little playful – as if one of the world’s largest organizations putting together systematic reviews of evidence around health care interventions could be a […]

  • 1
  • 2
  • Next »

Toolkit

Tips & Resources for Analyzing Health Care Claims

Surrogate markers may not tell the whole story

Screening: How overdiagnosis and other harms can undermine the benefits

A place to tell stories of patient harm from misleading media

View More

Toolkit

Institutional Home

University of Minnesota - School of Public Health

Our Reviewers

Deanna Attai, MD, FACS
Earle Holland
Dave Mosher
Andrew Holtz, MPH
Adam Cifu, MD
Kevin Lomangino
Michael Joyce, MD
Chioma  Ihekweazu, PhD, MPH
Susan Molchan, MD, MA
Kathlyn Stone
Joy Victory
Joann Rodgers, MS
Yoni Freedhoff, MD
Christine K. Norton, MA
Suzanne Hicks, MSW
Mary Chris Jaklevic
Harold J. DeMonaco, MS
Michael Bierer MD, MPH
Christopher Labos, MD
Jill U. Adams
A'ndrea Elyse Messer, MS, PhD
Alan Schroeder, MD
Preeti N. Malani, MD, MSJ
Sharon Dunwoody, PhD
More About Us
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • About Us
  • Toolkit
  • Contact

Copyright © 2021 HealthNewsReview.org